Good Manufacturing Practice (GMP) compliance is not optional for pharmaceutical manufacturers — it is the foundation of product quality, patient safety, and regulatory market access. For Indian pharmaceutical manufacturers targeting domestic, regulated export markets (US FDA, EU EMA, UK MHRA, WHO PQ), every aspect of the packaging operation must be GMP-aligned: the facility, the equipment, the processes, and the people.

The Regulatory Framework — Schedule M, WHO GMP & International Standards

Schedule M (India) — The principal GMP standard for pharmaceutical manufacturers in India, Schedule M under the Drugs and Cosmetics Act specifies requirements for premises, equipment, sanitation, documentation, quality control, and manufacturing operations. The 2023 revision significantly strengthened Schedule M requirements, aligning them more closely with WHO GMP guidelines.

WHO GMP — World Health Organization guidelines are the international benchmark, referenced by regulators in over 100 countries. WHO Technical Report Series (TRS) 986 covers packaging operations specifically.

EU GMP (EudraLex Vol. 4) — Required for pharmaceutical manufacturers exporting to the European Union. Annex 1 (sterile manufacturing), Annex 6 (manufacture of medicinal gases), and the main text all include requirements relevant to packaging.

US FDA 21 CFR Part 211 — Governs Current Good Manufacturing Practice for finished pharmaceutical products in the US market. Subpart G (packaging and labelling control) and Subpart E (equipment) are particularly relevant.

For most Indian pharmaceutical manufacturers, aligning with WHO GMP satisfies Schedule M while also supporting applications to multiple export markets simultaneously.

GMP Equipment Requirements for Pharmaceutical Packaging

Schedule M and WHO GMP both specify that pharmaceutical packaging equipment must be:

Suitable for intended use — Equipment must be capable of performing its intended function consistently and reproducibly. For packaging machinery, this means demonstrated capability studies (IQ/OQ/PQ) showing the equipment produces compliant product within validated parameters.

Constructed of appropriate materials — Product-contact surfaces must not react with, adsorb, or release substances affecting product quality. Stainless steel SS 316L is the pharmaceutical industry standard for product-contact equipment surfaces. Non-product contact structural elements typically use SS 304 or mild steel with appropriate coating.

Cleanable and maintainable — All equipment surfaces must be accessible for cleaning and must not accumulate product or cleaning agents. Hygienic design principles apply: no dead legs, smooth internal radii, drainable geometry, and accessible seals.

Calibrated and qualified — All measuring instruments on packaging equipment (fill volumes, weights, seal temperatures, speeds) must be calibrated on defined schedules with calibration certificates traceable to national standards.

Material Selection — Why SS 316L is the Pharmaceutical Standard

Stainless steel grade 316L (low-carbon variant) is the predominant material for pharmaceutical product-contact equipment surfaces for compelling reasons:

·- Corrosion resistance — The molybdenum content of SS 316L (2–3%) provides superior resistance to chloride attack compared to SS 304 — critical in pharmaceutical environments where chloride-containing cleaning agents (sodium hypochlorite) are widely used - Surface finish compatibility — SS 316L accepts electropolishing and mechanical polishing to Ra values well below the industry standard ≤0.8μm, with Ra ≤0.4μm achievable - Chemical compatibility — Compatible with the vast majority of pharmaceutical APIs and excipients - Regulatory acceptance — Specified in European Pharmacopoeia, USP, and all major international GMP guidelines - Weldability — The low carbon content minimises sensitisation during welding, maintaining corrosion resistance in weld heat-affected zones

For non-product contact structural components, SS 304 provides adequate corrosion resistance at lower cost. Engineering plastics (PEEK, PTFE, Delrin) are used for specific applications — bearings, seals, and guide components — where regulatory compliance must be verified.

Surface Finish Requirements for GMP Pharmaceutical Equipment

Surface finish is measurable and auditable — regulators and auditors will check Ra values on critical surfaces during GMP inspections. The key standards are:

·- Ra ≤0.8μm — Standard GMP requirement for internal product-contact surfaces of pharmaceutical equipment. This is a satin finish, achievable by mechanical polishing - Ra ≤0.4μm — Required for aseptic processing applications and sterile manufacturing. Achievable by fine mechanical polishing followed by electropolishing - Ra ≤0.2μm (electropolished) — For highest-criticality sterile applications. Electropolishing removes a microscopic layer of stainless steel surface, simultaneously smoothing and passivating — leaving a chromium-rich, highly corrosion-resistant surface

All surface finish measurements should be performed with calibrated profilometers, with results documented in surface finish certificates included in the equipment qualification package.

Equipment Qualification — IQ, OQ, PQ for Packaging Equipment

GMP requires that all critical pharmaceutical equipment be qualified before use in production. The three-stage approach is universal:

Installation Qualification (IQ) — Documents that equipment is installed correctly: correct location, utilities (power, compressed air, chilled water) to specification, all components present and correct, equipment identification and calibration status documented.

Operational Qualification (OQ) — Demonstrates equipment operates within specified parameters across its operating range — typically including worst-case testing. For packaging machinery, OQ includes verification of all process parameters: fill accuracy, seal integrity at temperature extremes, speed control, reject mechanism function, and alarms.

Performance Qualification (PQ) — Confirms the equipment consistently performs within specification under normal production conditions. PQ is typically conducted with actual product, at production scale, over multiple batches.

Machinery manufacturers who provide Factory Acceptance Test (FAT) support and comprehensive documentation (drawings, material certificates, calibration records, test protocols) significantly accelerate the IQ/OQ process at the manufacturer's site.

Selecting GMP-Compliant Packaging Machinery — A Practical Checklist

Use this checklist when evaluating pharmaceutical packaging machinery for GMP compliance:

☐Material certificates — SS 316L for all product-contact surfaces, with mill test certificates ☐ Surface finish documentation — Ra values measured and certified for critical surfaces ☐ Hygienic design — No dead legs, smooth radii, fully drainable, accessible for cleaning ☐ Seal materials — FDA-compliant (PTFE, EPDM, silicone) with certificates ☐ Calibration — All instruments calibrated, certificates traceable to national standards ☐ FAT protocol — Written FAT procedure, witnessed test at manufacturer's facility ☐ Documentation package — Technical drawings, P&ID diagrams, spare parts list, maintenance manual ☐ Cleaning procedure — Written CIP/SOP for cleaning, validated cleaning protocol ☐ Change control documentation — Procedure for managing equipment changes during lifecycle ☐ Spare parts commitment — Parts availability commitment, recommended spare parts list

ARK Pharmatech Solutions, based in Ahmedabad, Gujarat, designs and manufactures pharmaceutical packaging machinery aligned to these requirements — with FAT support, material traceability, and complete documentation packages as standard. Contact us at sales@arkpharmatech.com.

GMP pharmaceutical packaging Indiapharmaceutical packaging standards IndiaSchedule M packaging machineryGMP packaging equipment Indiapharmaceutical packaging compliance

GMP-Compliant Pharmaceutical Packaging: Standards, Equipment & Best Practices for Indian Manufacturers